Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akari, Alethia, Anavex, Appili, Astellas, Calcimedica, Chiesi, Fibrogen, Genexine, I-Mab, Passage Bio.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Acea, Adma Biologics, AGC Biologics, Anges, Beigene, Beximco, Celularity, Genexine, I-Mab, IMV, Kleo, KBP Bioscience, Medison, Nanomab, Orion, Progenabiome, Sorrento, Sutrovax, Synlogic, Takara, Vanda, Vaxcyte.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Antisense, Apollomics, Arvelle, Entera Bio, Galapagos, Gilead, Kadmon, Poseida, Tonix.

Biopharmas raising money in public or private financings, including: Arcturus, American Brivision, Flexion, FSD, Midatech, Nanoviricides, Nautilus, Nervgen, Pharmadrug, Scpharmaceuticals, Ultragenyx.

New hires and promotions in the biopharma industry, including: Amphista, Atreca.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Baxter.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Beyond Air, Livanova, Sera Prognostics.

Med-tech firms raising money in public or private financings, including: Assure Holdings, BBS-Bioactive Bone Substitutes, Becton Dickinson, Ra Medical Systems.

New hires and promotions in the med-tech industry, including: Brainsway, Seer.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Atea, Eiger, Evoke, Fate, Foundation, Incyte, Karyopharm, Merck, Morphosys, Octapharma.